258 results
8-K
EX-99.1
RGEN
Repligen Corp.
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
(Expense)
$2M - $3M
$18M - $19M
Adjusted EBITDA Margin
Tax Rate on Pre-Tax Income
Net Income
$26M - $30M
$80M - $84M
Earnings Per Share - Diluted
Our non … ; adjusted cost of sales; adjusted R&D expense; adjusted SG&A expense; adjusted pre-tax income; adjusted income from operations; adjusted net income
8-K
EX-4.1
31hcfxtbj4ot8i5zj6b
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
ii8t3dtpb
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
8-K
EX-99.1
d3s3k 1ybu24760
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
EX-10.1
ucpy fin2jorw
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
EX-99.1
hy1aotq9 39tv
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
EX-99.1
yg4t 6tomjb3a
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
jof6vli1th
1 Nov 22
Repligen Reports Third Quarter 2022 Financial Results
7:54am
8-K
EX-10.2
x7dpq7 z0snqu35oe
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm